For more information on Replagal (Replagal product-related inquiries), please contact our Medical Information department. Please select the contact details for your region. We look forward to hearing from you.
Asia, Australia and New Zealand:
European countries and Middle East and Africa:
Nothing is more important to us than the safety of the people who use our treatments. For that reason, we are constantly working to identify, understand, minimise and communicate any adverse effects associated with our medicines.
Our Pharmacovigilance Department continually evaluates and monitors the safety of our treatments after they reach the marketplace. Adverse events are reported to relevant health authorities, and the information is used to continually update the risk/benefit profile of our medicines.
From detailed risk management plans to periodic assessments and inspections made by major regulatory authorities, our robust safety governance process ensures we respond to safety issues quickly, appropriately, and in compliance with global legislation and regulations. To report suspected side effects for Shire products, please contact firstname.lastname@example.org. If you are a healthcare professional, you can contact Shire Medical Information by visiting www.shiremedinfo.com.